Wedbush Securities’s Iovance Biotherapeutics IOVA Stock Holding History

Wedbush Securities’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$605K	Buy	+145,473	New	+$553K	0.02%	659

Other funds holding IOVA

MCP

Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

LSA

Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return

SMAM

Sugar Maple Asset Management Sister Bay, Wisconsin $155M AUM 17.72% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Wedbush Securities's IOVA Position: Q2 2026 in Review

Wedbush Securities opened a new position in Iovance Biotherapeutics (IOVA) in Q2 2026: 145,473 shares worth $605K. The stake represents 0.02% of the portfolio and ranks #659 among its holdings.

51 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

Wedbush Securities held 145,473 shares of Iovance Biotherapeutics worth $605K as of Q2 2026.
Iovance Biotherapeutics was a new Wedbush Securities position in Q2 2026.
Iovance Biotherapeutics made up 0.02% of Wedbush Securities's portfolio in Q2 2026, its #659 holding.
51 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Wedbush Securities's 13F filing for Q2 2026, filed 28 Jul 2026.